Navigation Links
Better Prostate Cancer Test

Any man who's been through a prostate biopsy will tell you it’s not a pleasant experience. Now a new technique could lead to a better blood test for prostate cancer and eliminate the need for unnecessary biopsies for many men.
Bob Miles has had three biopsies of his prostate after blood tests revealed elevated levels of PSA -- a protein that when elevated indicates the possibility of prostate cancer. "Every time they take a section through the prostate the needle clicks, You hear it, //and then you feel the stab of pain," says Bob Miles.

Miles says it’s an unpleasant experience, but says it’s nothing compared to the pain of watching his father die from prostate cancer. "For me, that was an enormous incentive to go through the experience," he says.

All of Miles' biopsies were negative. And they’re negative for as many as 75 percent of men who have them.

Now, instead of having to go through the pain of a biopsy, patients may only have to have a blood test to rule out cancer.What this new test does is looks at thousands of proteins at the same time rather than just the one protein and looks at the pattern of those proteins.

In a study, the new test accurately detected cancer 100 percent of the time. It correctly ruled it out in about 65 percent of cases where the PSA level was high enough to warrant a biopsy.

Miles hopes the test will help men like him avoid future biopsies.Researchers say larger clinical trials are still needed before the test is available to doctors and their patiets.
'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Drug for Heart Transplant
9. Better Diet Even Late in Life May Prolong It
10. Better Care Required for Breast Cancer Survivors
11. Two drugs Mays Be Better Than One For Prostate Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... San Francisco, California (PRWEB) , ... December 08, 2016 , ... ... health coaches, has raised an $18M Series B led by Canvas Ventures . ... use the capital to scale its mobile platform to serve more consumers who are ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dan Carlisle Agency, ... Jefferson County, is announcing the launch of a charity drive to raise support ... homeless women and children in Birmingham has grown steadily since the 1980’s, and ...
(Date:12/8/2016)... , ... December 08, 2016 , ... The Compretta Insurance ... and residential clients in and around the Hancock County area, is announcing the launch ... County Food Pantry. , The Hancock County Food Pantry has worked for more than ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... DrugDev ... the announcement that it is one of the early adopters completing EU-U.S. Privacy Shield ... is designed to provide companies on both sides of the Atlantic with a mechanism ...
(Date:12/7/2016)... Kenosha, Wisconsin (PRWEB) , ... December 07, 2016 , ... ... the extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED ... the right amount of light where and when it’s needed. , A ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... offer newly issued shares of common stock, $0.01 par value ... an underwritten public offering.  The final terms of the Offering ... of pricing, and there can be no assurance as to ... IRIDEX expects to use the net proceeds it will receive ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... 2016  Eli Lilly and Company (NYSE: ... 3 EXPEDITION3 trial at the 9 th Clinical ... solanezumab did not meet the primary endpoint in the ... people with mild dementia due to Alzheimer,s disease (AD), ... for the treatment of mild dementia due to AD. ...
Breaking Medicine Technology: